Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press Series of Journals Center for Evidence-Based and Translational Medicine of Wuhan University

The title
  • The title
  • The keywords
  • The author
Submit中文版

HomeArticlesVol 30,2020 No.5Detail

An analysis of disease burden of bladder cancer in China from 1990 to 2017

Published on Oct. 14, 2020Total Views: 7867 timesTotal Downloads: 3504 timesDownloadMobile

Author: Hao ZI 1 Mou PENG 2, 3 Jiang-Yi WANG 4 Hai-Liang HU 5 Lu YANG 6 Hai-Jun YAO 7 Zheng CHEN 8 Jing-Cheng ZHOU 9, 10 Jia GUO 11 Xiao-Feng XU 12 Li-Sha LUO 1 Xiao-Dong LI 13 Zhong-Yi SUN 14 Hong WENG 15 Tao ZENG 16* Xian-Tao ZENG 1, 15, 17*

Affiliation: 1. Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 2. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA 3. Department of Urology, The Second Xiangya Hospital of Central South University, Changsha 410011, China 4. Department of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China 5. Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA 6. Department of Urology, West China Hospital of Sichuan University, Chengdu 610041, China 7. Department of Urology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China 8. Department of Urology, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China 9. Department of Urology, Peking University First Hospital, Beijing 100034, China 10. Institute of Urology, Peking University, Beijing 100034, China 11. Department of Urology, Renmin Hospital of Wuhan University, Wuhan 430060, China 12. Department of Urology, Xianyang Central Hospital, Xianyang 712000, Shaanxi Province, China 13. Institute of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng 475000, Henan Province, China 14. Department of Urology, Shenzhen Hospital, Peking University, Shenzhen 518036, Guangdong Province, China 15. Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China 16. Department of Urology, Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang 330006, China 17. Division of Personnel Services, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

Keywords: Bladder cancer Incidence Mortality Burden of disease Disability-adjusted life year

DOI: 10.12173/j.issn.1004-5511.2020.05.01

Reference: Zi H, Peng M, Wang JY, Hu HL, Yang L, Yao HJ, Chen Z, Zhou JC, Guo J, Xu XF, Luo LS, Li XD, Sun ZY, Weng H, Zeng T, Zeng XT. An analysis of disease burden of bladder cancer in China from 1990 to 2017[J]. Yixue Xinzhi Zazhi, 2020, 30(5): 328-335. DOI: 10.12173/j.issn.1004-5511.2020.05.01.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To analyze the trend of disease burden of bladder cancer in China from 1990 to 2017. 

Methods  Data were obtained from the results of Global Burden of Disease Study 2017 (GBD 2017). Bladder cancer incidence, mortality, disability-adjusted life year (DALY), years of life lost (YLL), and years lived with disability (YLD) were used to describe the changes of disease burden of bladder cancer in Chinese population between 1990 and 2017. The incidence, mortality, DALY rate, YLL rate, and YLD rate were standardized by the Global Burden of Disease (GBD) global standard population in 2017. 

Results  In 2017, the number of new cases of bladder cancer in China was 73,000 with the standardized incidence rate of 3.89/100,000 and the number of deaths was 30,600 with the standardized mortality rate of 1.75/100,000. Compared to 1990, the number of new cases increased by 164.49% accompanying with the increased incidence rate by 15.09% and the number of deaths increased by 92.45% but accompanying with the decreased standardized mortality rate by 23.58%. Furthermore, male’s incidence and mortality were higher than that of female and showed an upward trend with aging. Compared to 1990, the standardized DALY rate and standardized YLL rate of bladder cancer in China in 2017 decreased by 26.35% and 28.59%, respectively, and the standardized YLD rate increased by 28.83%. From 1990 to 2017, the DALY rate of bladder cancer in China showed a downward trend, but the DALY rate of male was still higher than that of female. 

Conclusions  From 1990 to 2017, the standardized incidence rate of bladder cancer in China continued to rise, and the standardized mortality rate showed a downward trend. Male and elder population was the high-risk population for bladder cancer.

Full-text
Please download the PDF version to read the full text: download
References

1.Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Akinyemiju TF, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: A systematic analysis for the Global Burden of Disease Study[J]. JAMA Oncol, 2018, 4(11): 1553-1568. DOI: 10.1001/jamaoncol.2018.2706.

2.Ebrahimi H, Amini E, Pishgar F, et al. Global, regional and national burden of bladder cancer, 1990 to 2016: Results from the GBD Study 2016[J]. J Urol, 2019, 201(5): 893-901. DOI: 10.1097/ju.0000000000000025.

3.贺宇彤, 李道娟, 梁迪, 等. 2014年中国膀胱癌发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(9): 647-652. DOI: 10.3760/cma.j.issn.0253-3766.2018.09.002. [He YT, Li DJ, Liang D, et al. Incidence and mortality of bladder cancer in China, 2014[J]. Chinese Journal of Oncology, 2018, 40(9): 647-652.]

4.温登瑰, 单保恩, 张思维, 等. 2003—2007年中国肿瘤登记地区膀胱癌的发病与死亡分析[J]. 肿瘤, 2012, 32(4): 256-262. DOI: 10.3781/j.issn.1109-0721. 2012.04.006. [Wen DG, Shan BE, Zhang SW, et al. Analysis of incidence and mortality rates of bladder cancer in registration areas of China from 2003 to 2007[J]. Tumor, 2012, 32(4): 256-262.] 

5.张思维, 马建辉, 李鸣, 等. 中国部分市县膀胱癌发病趋势比较研究[J]. 中华泌尿外科杂志, 2009, 30(10): 673-676. DOI: 10.3781/j.issn.1109-0721.2012.04.006. [Zhang SW, Ma JH, Li M, et al. Incidence trends of bladder cancer in cities and counties in China[J]. Chinese Journal of Urology, 2009, 30(10): 673-676.]

6.韩苏军, 张思维, 陈万青, 等. 中国膀胱癌发病现状及流行趋势分析[J]. 癌症进展, 2013, 11(1): 89-95. DOI: 10.3969/j.issn.1672-1535.2013.01.021. [Han SJ, Zhang SW, Chen WQ, et al. Analysis of the status and trends of bladder cancer incidence in China[J]. Oncology Progress, 2013, 11(1): 89-95.]

7.James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.

8.Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1859-1922. DOI: 10.1016/S0140-6736(18)32335-3.

9.Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159): 1736-1788. DOI: 10.1016/S0140-6736(18)32203-7.

10.周脉耕, 陈万青. 开展肿瘤疾病负担研究, 推动肿瘤防治科学决策[J]. 中华流行病学杂志, 2016, 37(6): 749-751. DOI: 10.3760/cma.j.issn.0254-6450.2016.06.001. [Zhou MG, Chen WQ, Research on burden of cancer to promote scientific development of cancer prevention and control[J]. Chinese Journal of Epidemiology, 2016, 37(6): 749-751.]

11.刘韫宁, 刘江美, 殷鹏, 等. 1990年与2010年中国恶性肿瘤疾病负担研究[J]. 中华预防医学杂志, 2015, 49(4): 309-314. DOI: 10.3760/cma.j.issn.0253-9624. 2015.04.006. [Liu YN, Liu JM, Yin P, et al. The disease burden of malignant tumor in China, 1990 and 2010[J]. Chinese Journal of Preventive Medicine, 2015, 49(4): 309-314.]

12.Burger M, Catto JW, Dalbagni G, et al. Epidemiology and risk factors of urothelial bladder cancer[J]. Eur Urol, 2013, 63(2): 234-241. DOI: 10.1016/j.eururo.2012.07.033.

13.Osch FH, Jochems SH, Schooten FJ, et al. Quantified relations between exposure to tobacco smoking and bladder cancer risk: A meta-analysis of 89 observational studies[J]. Int J Epidemiol, 2016, 45(3): 857-870. DOI: 10.1093/ije/dyw044.

14.Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women[J]. JAMA, 2011, 306(7): 737-745.DOI: 10.1001/jama.2011.1142.

15.Colt JS, Friesen MC, Stewart PA, et al. A case-control study of occupational exposure to metalworking fluids and bladder cancer risk among men[J]. Occup Environ Med, 2014, 71(10): 667-674. DOI: 10.1136/oemed-2013-102056.

16.Pesch B, Taeger D, Johnen G, et al. Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines[J]. Int Arch Occup Environ Health, 2014, 87(7): 715-724. DOI: 10.1007/s00420-013-0916-3.

17. 戴奇山, 何慧婵, 蔡超, 等. 吸烟与中国人膀胱癌相关性的多中心病例对照研究[J]. 中华医学杂志, 2011, 91(34): 2404-2410. DOI: 10.3760/cma.j.issn.0376-2491. 2011.34.008. [Dai QS, He HC, Cai C, et al. Multicenter case-control study of the relationship between smoking and bladder cancer in China[J]. National Medical Journal of China, 2011, 91(34): 2404-2410.]

18. 夏溟, 臧美孚, 李汉忠, 等. 中国职业性膀胱癌的生物学监测及其意义[J]. 中华泌尿外科杂志, 2003, 24(10): 684-685. DOI: 10.3760/j:issn:1000-6702.2003.10.012. [Xia M, Zang MF, Li HZ, et al. The biological monitoring and its significance in the diagnosis of occupational bladder cancer[J]. Chinese Journal of Urology, 2003, 24(10): 684-685.]

19. 代珍, 李纪宾, 陈元立, 等. 中国居民吸烟与男性膀胱癌死亡率关系的研究[J]. 中华肿瘤防治杂志, 2012, 19(11): 809-813. [Dai Z, Li JB, Chen YL, et al. Relation between smoking and bladder cancer mortality in males of China[J]. Chinese Journal of Cancer Prevention and Treatment, 2012, 19(11): 809-813.]

20. 杨之洵, 曾红梅, 郑荣寿, 等. 大气污染与主要癌症相关性研究进展[J]. 中华流行病学杂志, 2018, 39(4): 532-535. DOI: 10.3760/cma.j.issn.0254-6450.2018.04.029. [Yang ZX, Zeng HM, Zheng RS, et al. Progress of research on the association between air pollution and prevalence of major cancers[J]. Chinese Journal of Epidemiology, 2018, 39(4): 532-535.]

Popular Papers
© 2022 - 2024 Zhongnan Medical Journal Press of Zhongnan Hospital of Wuhan University|Support: Yufu Technology
About NM | Contact us